Subjects With Serious Adverse Events by System Organ Class and Preferred Term


This table shows patients with serious adverse events by system organ class and preferred term in the safety population.

This display is based on Table 9. Patients With Serious Adverse Events by System Organ Class and Preferred Term from the FDA STANDARD SAFETY TABLES AND FIGURES: INTEGRATED GUIDE (Version Date: August 2022), published by the Center for Drug Evaluation and Research (CDER) Biomedical Informatics and Regulatory Review Science (BIRRS) Team.


This display was created using data from the following ADaM datasets

  • ADSL, ADAE

The ADaM datasets from the CDISC Pilot Study were modified as follows

  • Only variables that were needed to create this display have been retained.

  • If needed, additional variables were added to support the creation of the display.

The following differences exist between the display shown and the reference display from the FDA Standard Tables and Figures: Integrated Guide

  • The display shown uses the word "Subject" vs "Patient" to be consistent with the language used in CDISC standards.

  • The display shows two Risk Differences, one for each dose compared to the placebo.

  • The display does not show an active control as this does not exist in the CDISC Pilot Study data.


Subjects With Serious Adverse Events by System Organ Class and Preferred Term

Package
FDA-AE-T09 eTFL Package